search
Back to results

Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization (PAPR)

Primary Purpose

Respiratory Failure, COVID-19

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Intermittent prone positioning instructions
Usual care positioning with no instructions
Sponsored by
University of Utah
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Failure focused on measuring COVID-19, Respiratory failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult (age ≥ 18 years)
  • Suspected or Confirmed COVID-19 (Suspected: High clinical suspicion AND pending COVID-19 assay; Confirmed: Positive COVID-19 assay within 10 days)
  • Scheduled for admission or already admitted to an inpatient hospital bed
  • Patients must be enrolled within 48 hours of hospital admission

Exclusion Criteria:

  • Pregnant
  • Prisoner
  • Contraindication to prone positioning: known increased intracranial pressure >30 mm Hg or cerebral perfusion pressure <60 mm Hg, increased abdominal pressure or risk for abdominal compartment syndrome, massive hemoptysis requiring urgent intervention, tracheal surgery or sternotomy during previous 14 days, facial surgery or serious facial trauma within 14 days, pacemaker implantation within 48 hours, unstable spine, femur, or pelvic fractures, chest tube, mean arterial pressure less than 65 mm Hg
  • Lung transplant
  • Burns on more than 20% of body surface
  • Chronic respiratory failure requiring: mechanical ventilation via endotracheal device (e.g. tracheostomy tube, orotracheal tube, or nasotracheal tube)
  • Inability to change position from supine to prone and prone to supine without assistance
  • Receiving end of life care, comfort measures only, or hospice

Sites / Locations

  • University of Utah Health Sciences Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Prone Positioning

Usual care

Arm Description

Outcomes

Primary Outcome Measures

Change in imputed partial pressure of oxygen over fraction of inspired oxygen (PaO2/FiO2) from peripheral capillary oxygen saturation over fraction of inspired oxygen (SpO2/FiO2)

Secondary Outcome Measures

Change in imputed PaO2/FiO2 from SpO2/FiO2
Proportion of participants requiring endotracheal intubation
Proportion of participants requiring mechanical ventilation
Proportion of participants transferred to intensive care for worsening respiratory failure
Proportion of participants who had escalated oxygen delivery needs
Average number of days hospitalized
Average number of ventilator-free days
Proportion of participants discharged from hospital on hospice
Proportion of participants with all-cause inpatient mortality

Full Information

First Posted
April 24, 2020
Last Updated
December 1, 2020
Sponsor
University of Utah
search

1. Study Identification

Unique Protocol Identification Number
NCT04368000
Brief Title
Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization
Acronym
PAPR
Official Title
Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Terminated
Why Stopped
Study was terminated due to lack of adherence to the protocol in the intervention arm.
Study Start Date
April 29, 2020 (Actual)
Primary Completion Date
August 6, 2020 (Actual)
Study Completion Date
August 6, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Utah

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Acute respiratory distress syndrome (ARDS) is a major complication among patients with severe disease. In a report of 138 patients with COVID-19, 20% developed ARDS at a median of 8 days after the onset of symptoms, with 12.3% of patients requiring mechanical ventilation. Efficacious therapies are desperately needed. Supportive care combined with intermittent prone positioning may improve outcomes. Prone positioning (PP) of patients with severe ARDS (when combined with other lung-protective ventilation strategies) is associated with a significant mortality benefit. In addition, PP for >12 hours in severe ARDS is strongly recommended by clinical practice guidelines. The aim of this study is to compare the outcomes of prone positioning versus usual care positioning in non-intubated patients hospitalized for COVID-19.
Detailed Description
In December 2019, an outbreak of a novel coronavirus (SARS-CoV-2) emerged in Wuhan, China and rapidly spread worldwide. The World Health Organization (WHO) declared the outbreak a pandemic on March 11th, 2020. The clinical disease (COVID-19) is mild in 81% of patients, severe disease occurs in 14%, and 5% of cases result in critical illness. The reported overall case fatality rate (CFR) is 2.3% in China, although the CFR varies widely (0.7- 7.2%) between regions. Older age is associate with increased mortality. The reported CFR is 8% among patients 70-79 years old and 15% in those 80 years and older. Multiple therapies have been proposed based on in vitro evidence or anecdotal reports. Although, no high quality clinical trials have demonstrated an effective treatment regimen other than supportive care. Acute respiratory distress syndrome (ARDS) is a major complication among patients with severe disease. In a report of 138 patients with COVID-19, 20% developed ARDS at a median of 8 days after the onset of symptoms, with 12.3% of patients requiring mechanical ventilation. Efficacious therapies are desperately needed. Supportive care combined with intermittent prone positioning may improve outcomes. Prone positioning (PP) of patients with severe ARDS (when combined with other lung-protective ventilation strategies) is associated with a significant mortality benefit. In addition, PP for >12 hours in severe ARDS is strongly recommended by clinical practice guidelines. Improvements in gas exchange, cardiac output, and clearance of secretions have been demonstrated with PP, and are thought to contribute to the survival benefits. Low quality evidence from case series and retrospective studies in awake, spontaneously breathing patients suggest PP is feasible, improves oxygenation, and may avoid the need for mechanical ventilation. A recent prospective observational study of early PP combined with high-flow nasal cannula or non-invasive mechanical ventilation was well tolerated and may help patients avoid intubation. This study is a single-center non-blinded randomized controlled pragmatic feasibility study comparing the outcomes of prone positioning (intervention) versus usual care (control) in non-intubated patients hospitalized for COVID-19.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Failure, COVID-19
Keywords
COVID-19, Respiratory failure

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Prone Positioning
Arm Type
Experimental
Arm Title
Usual care
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
Intermittent prone positioning instructions
Intervention Description
Participants will be given instructions to lie in the prone position for a duration of 1-2 hours, every 4 hours while awake.
Intervention Type
Behavioral
Intervention Name(s)
Usual care positioning with no instructions
Intervention Description
Participants will not be given instructions to lie in the prone position for any duration.
Primary Outcome Measure Information:
Title
Change in imputed partial pressure of oxygen over fraction of inspired oxygen (PaO2/FiO2) from peripheral capillary oxygen saturation over fraction of inspired oxygen (SpO2/FiO2)
Time Frame
72 hours
Secondary Outcome Measure Information:
Title
Change in imputed PaO2/FiO2 from SpO2/FiO2
Time Frame
48 hours
Title
Proportion of participants requiring endotracheal intubation
Time Frame
Up to 8 weeks
Title
Proportion of participants requiring mechanical ventilation
Time Frame
Up to 8 weeks
Title
Proportion of participants transferred to intensive care for worsening respiratory failure
Time Frame
Up to 8 weeks
Title
Proportion of participants who had escalated oxygen delivery needs
Time Frame
Up to 8 weeks
Title
Average number of days hospitalized
Time Frame
Up to 8 weeks
Title
Average number of ventilator-free days
Time Frame
Up to 8 weeks
Title
Proportion of participants discharged from hospital on hospice
Time Frame
Up to 8 weeks
Title
Proportion of participants with all-cause inpatient mortality
Time Frame
Up to 8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult (age ≥ 18 years) Suspected or Confirmed COVID-19 (Suspected: High clinical suspicion AND pending COVID-19 assay; Confirmed: Positive COVID-19 assay within 10 days) Scheduled for admission or already admitted to an inpatient hospital bed Patients must be enrolled within 48 hours of hospital admission Exclusion Criteria: Pregnant Prisoner Contraindication to prone positioning: known increased intracranial pressure >30 mm Hg or cerebral perfusion pressure <60 mm Hg, increased abdominal pressure or risk for abdominal compartment syndrome, massive hemoptysis requiring urgent intervention, tracheal surgery or sternotomy during previous 14 days, facial surgery or serious facial trauma within 14 days, pacemaker implantation within 48 hours, unstable spine, femur, or pelvic fractures, chest tube, mean arterial pressure less than 65 mm Hg Lung transplant Burns on more than 20% of body surface Chronic respiratory failure requiring: mechanical ventilation via endotracheal device (e.g. tracheostomy tube, orotracheal tube, or nasotracheal tube) Inability to change position from supine to prone and prone to supine without assistance Receiving end of life care, comfort measures only, or hospice
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stacy A Johnson, MD
Organizational Affiliation
University of Utah
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Utah Health Sciences Center
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84132
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization

We'll reach out to this number within 24 hrs